CG Oncology Inc. Common s... (CGON)
NASDAQ: CGON
· Real-Time Price · USD
25.39
-0.17 (-0.67%)
At close: Aug 20, 2025, 9:45 AM
CG Oncology Common stock Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Net Income | -41.43M | -34.45M | -31.8M | -20.41M | -18.9M | -16.93M | -16.55M | -11.77M | -11.62M | -8.67M | -8.39M |
Depreciation & Amortization | 156K | 24K | n/a | 21K | 7K | 4K | -5K | 5K | 4K | 4K | 4K |
Stock-Based Compensation | 7.01M | 5.15M | 4.99M | 2.65M | 2.25M | 1.52M | 778K | 394K | 177K | 179K | 148K |
Other Working Capital | 8.49M | -181K | 3.1M | 3.77M | 3.17M | -9.82M | 780K | -394K | n/a | 382K | 1.12M |
Other Non-Cash Items | -2.36M | -469K | 1.25M | -1.59M | -2.48M | -2.2M | -2.44M | 328K | 621K | 125K | 107K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 8.66M | 469K | 4.9M | 3.4M | 3.01M | -8.4M | 2.16M | 195K | 286K | 373K | 1.3M |
Operating Cash Flow | -27.96M | -29.28M | -20.66M | -15.92M | -16.12M | -26.01M | -16.06M | -10.85M | -10.79M | -7.99M | -6.83M |
Capital Expenditures | -14K | -16K | -209K | 1K | -14K | -12K | n/a | 6K | -6K | n/a | 1K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -167.96M | -361.89M | -217.07M | -169.24M | -206.34M | -453.3M | -379.47M | -192.05M | -32.35M | -78.7M | -55.34M |
Sales Maturities Of Investments | 170.38M | 200.14M | 228.18M | 201.24M | 170.13M | 145.87M | n/a | 30.66M | 135.71M | n/a | n/a |
Other Investing Acitivies | -1M | -25M | n/a | n/a | n/a | n/a | 396.42M | -1.41M | n/a | -78.7M | -55.34M |
Investing Cash Flow | 1.41M | -186.77M | 10.9M | 32.01M | -36.23M | -307.44M | 16.94M | -162.8M | 103.36M | -78.7M | -55.34M |
Debt Repayment | n/a | n/a | 365K | n/a | n/a | -365K | -1K | -67K | -15.39M | -833K | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -296K | n/a | -365K | n/a | n/a | -3.39M | -2.89M | 105.94M | 165K | 68K | n/a |
Financial Cash Flow | -296K | 450K | 223.41M | 2.17M | 40K | 402.66M | -2.89M | 105.88M | -15.22M | -765K | 56.7M |
Net Cash Flow | -26.85M | -215.6M | 213.66M | 18.25M | -52.31M | 69.2M | -2.01M | -67.77M | 77.35M | -87.45M | -5.47M |
Free Cash Flow | -27.97M | -29.29M | -20.87M | -15.92M | -16.13M | -26.02M | -16.06M | -10.84M | -10.79M | -7.99M | -6.83M |